Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Chesnara Plc
Good 2023 results set platform for future progress
11th Apr 2024
Tissue Regenix
Six consecutive periods of >20% growth
10th Apr 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax enhanced research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
94: How governance enables startup growth and how to start it well | Dermot Campbell of SEEIO
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can still be accessed for free under MIFID II.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax enhanced research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Arbuthnot Banking Group Plc
Financials
2018 results: growth and diversity
By
Mark Thomas
29 Apr 2019
Diurnal Group Plc
Clarity for Chronocort regulatory pathway
By
Dr Gregoire Pave
25 Apr 2019
Warpaint London
Consumer
FY’18 sales: remains profitable despite weak UK market
By
Yingheng Chen
24 Apr 2019
City of London Investment Group
Financials
Market bounce gives FUM bounce
By
Dr Brian Moretta
17 Apr 2019
Advanced Oncotherapy
Life Sciences
Preparing for commercialisation
By
Dr Martin Hall
16 Apr 2019
Filta Group
Services
Strong and transformative year in 2018
By
Jason Streets
15 Apr 2019
ValiRx
Life Sciences
VAL401 is going forward
By
Dr Martin Hall
15 Apr 2019
Tissue Regenix
Life Sciences
Expanded GPO coverage secured
By
Dr Martin Hall
10 Apr 2019
Life Sciences
Global Pharmaceuticals: 2018 industry statistics
By
Dr Martin Hall
09 Apr 2019
Building & Construction
UK Housebuilding Sector in 1Q 2019
By
Tony Williams
09 Apr 2019
genedrive Plc
Life Sciences
First commercial sales in new focus area: bio-threats
By
Dr Dorothea Hill
08 Apr 2019
Prev
1
...
53
54
55
56
57
...
80
Next